GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Adicon Holdings Ltd (OTCPK:ADCNF) » Definitions » Common Stock

Adicon Holdings (Adicon Holdings) Common Stock : $0.0 Mil (As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Adicon Holdings Common Stock?

Adicon Holdings's quarterly common stock increased from Dec. 2022 ($0.0 Mil) to Jun. 2023 ($0.0 Mil) and increased from Jun. 2023 ($0.0 Mil) to Dec. 2023 ($0.0 Mil).

Adicon Holdings's annual common stock declined from Dec. 2021 ($0.0 Mil) to Dec. 2022 ($0.0 Mil) but then increased from Dec. 2022 ($0.0 Mil) to Dec. 2023 ($0.0 Mil).


Adicon Holdings Common Stock Historical Data

The historical data trend for Adicon Holdings's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adicon Holdings Common Stock Chart

Adicon Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Common Stock
0.01 0.01 0.01 0.01

Adicon Holdings Quarterly Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Common Stock Get a 7-Day Free Trial 0.01 - 0.01 0.01 0.01

Adicon Holdings Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Adicon Holdings (Adicon Holdings) Business Description

Comparable Companies
Traded in Other Exchanges
Address
No. 208, Zhenzhong Road, West Lake, Zhejiang, Hangzhou, CHN
Adicon Holdings Ltd is one of the top three independent clinical laboratory or ICL, service providers in China. The company offers comprehensive and best-in-class testing services primarily to hospitals and health check centers through an integrated network of 33 self-operated laboratories across China. The high quality of its services is backed by its strong performance in terms of international accreditation and comprehensive testing menu. Its testing portfolio consists of over 4,000 medical diagnostic tests, including over 1,700 routine tests and over 2,300 esoteric tests. It has three major service platforms. Among them, the inspection service platform consists of clinical, pathology, reproductive genetic, genetic, and mass spectrometry laboratories.

Adicon Holdings (Adicon Holdings) Headlines

No Headlines